These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6169957)

  • 41. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 42. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
    Koch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of moderate to severe hypertension with labetalol.
    Tötterman KJ; Eisalo A
    Acta Med Scand Suppl; 1981; 646():115-22. PubMed ID: 6941659
    [No Abstract]   [Full Text] [Related]  

  • 45. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 46. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 48. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 49. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract]   [Full Text] [Related]  

  • 50. Closing remarks: current status of labetalol.
    Dollery CT
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):823-4. PubMed ID: 10954
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 52. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
    Bakris G
    J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 56. A study of labetalol in patients of European, West Indian and West African origin.
    Jennings K; Parsons V
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):773-5. PubMed ID: 990155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which beta-blocker in pregnancy-induced hypertension?
    Lardoux H; Gerard J; Blazquez G; Flouvat B
    Lancet; 1983 Nov; 2(8360):1194. PubMed ID: 6139547
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 59. Labetalol: an alpha- and beta-adrenergic receptor blocker.
    Pepper GA
    Nurse Pract; 1985 Jul; 10(7):39-40, 43, 48. PubMed ID: 3855235
    [No Abstract]   [Full Text] [Related]  

  • 60. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.